Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGH in children with PTH/PTHrP signaling pathway disorders
ChiCTR2500098947Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Soochow University
- Start
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of somatropin in inactivating PTH/PTHrP signaling disorder (iPPSD) (2 arms), sponsored by Children's Hospital of Soochow University. Primary endpoint: Change in predicted adult height. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
somatropin
03
Conditions
inactivating PTH/PTHrP signaling disorder (iPPSD)
Beyond the preview
Go deeper on ChiCTR2500098947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098947.